Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing Antibodies
深度测序鉴定 HIV-1 中和抗体的 B 细胞前体
基本信息
- 批准号:9086242
- 负责人:
- 金额:$ 65.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffinityAntibodiesAntibody RepertoireAntibody ResponseAntigensAutologousB-LymphocytesBindingBloodBlood CellsBlood specimenCellsCloningComplexCritical PathwaysDevelopmentEpitopesGenomeGlycoproteinsGoalsHIV-1HealthHumanImmunityImmunizationIndividualInfectionMacaca mulattaMiningMonoclonal AntibodiesPlasmaProcessProductionReceptors, Antigen, B-CellResolutionSamplingSystemTechnologyTestingTimeVaccinationVaccine DesignVirusantigen bindingdeep sequencingdesignimmunogenicityinsightinterestlymph nodesneutralizing antibodyneutralizing monoclonal antibodiesresponsescreeningsimian human immunodeficiency virusvaccine development
项目摘要
DESCRIPTION: Our recent breakthroughs in applying single B-cell probing and cloning technologies to isolate human antibodies capable of potently and broadly neutralizing HIV-1 primary isolates, along with others, have demonstrated the ability of human B-cell system to generate effective immunity against the virus. To progress on this encouraging discovery and unearth mechanisms by which broadly neutralizing antibodies (bnAbs) could be elicited by immunization, we are challenged by two unsolved and fundamental immunological questions: what are the naive and/or founder (n/f) B-cells and their B-cell receptor (BCR) sequences that must be immunologically selected to generate anti-HIV-1 bnAbs, and how do these selected n/f BCRs react with the HIV-1 envelope (Env) antigen? Having access to precious longitudinal samples from both SHIV-infected rhesus macaques (including lymph nodes) and HIV-1- infected seroconverters, we have a unique opportunity to address these questions by identifying the n/f BCRs responsible for bnAbs and determining their reactivity to the Env antigen. In addition to single B-cell analysis, we have also pioneered the application of deep sequencing technology to mine anti-HIV-1 bnAbs of the whole antibody repertoire. With the aid of these advanced technologies that offer high- resolution analysis of both single and high-number (millions) B-cells, it is feasible to track bnAb responses, thereby catapulting our quest to identiy bnAb-corresponding n/f BCRs. Furthermore, we will isolate the autologous infecting HIV-1 Envs and investigate their reactivity with the n/f BCRs of interest. We will test the hypotheses that n/ BCRs that give rise to bnAbs in SHIV-infected rhesus macaques and HIV-1-infected humans can be identified by deep sequencing of the subject antibodyome from longitudinally collected blood and lymph node cells, and that the n/f BCRs recognize the autologous infecting HIV-1 Envs. If successful, this project will delineate a complex and lengthy B-cell immunological process, revealing the much anticipated initial steps that the HIV-1 Env antigen must take to initiate an effective antibody response. This project will also generate a panel of bnAb-corresponding n/f BCRs that would be invaluable for immunogen screening and may also identify HIV-1 Envs that have the potential to prime these n/f BCRs.
描述:我们最近在应用单个B细胞探测和克隆技术方面的突破来分离能够有效,广泛中和的HIV-1主要分离株的人类抗体以及其他抗体,也证明了人类B细胞系统对病毒产生有效免疫的能力。 To progress on this encouraging discovery and unearth mechanisms by which broadly neutralizing antibodies (bnAbs) could be elicited by immunization, we are challenged by two unsolved and fundamental immunological questions: what are the naive and/or founder (n/f) B-cells and their B-cell receptor (BCR) sequences that must be immunologically selected to generate anti-HIV-1 bnAbs, and how do these selected N/F BCR与HIV-1信封(ENV)抗原反应?我们可以从SHIV感染的恒河猕猴(包括淋巴结)和HIV-1感染的血清抗体中获取宝贵的纵向样品,我们有一个独特的机会来通过识别负责BNABS的N/F BCR来解决这些问题,并确定其对Env antigen的反应性。除了单个B细胞分析外,我们还开创了深层测序技术在整个抗体库中的抗HIV-1 BNABs的应用。在这些高级技术的帮助下,它们对单个和高数字(数百万)b细胞进行高分辨率分析,跟踪BNAB响应是可行的,从而迅速降低了我们寻求识别bnab对应的n/f bcrs的追求。此外,我们将隔离自体感染HIV-1 ENV,并研究其对N/F BCR的反应性。我们将测试以下假设,即可以通过对纵向收集的血液和淋巴结细胞的受试者抗体细胞的深度测序来鉴定出SHIV感染的恒河猕猴和HIV-1感染的人的N/ BCR,并可以鉴定出N/ F BCR的N/ F BCR识别N/ F BCR识别自动志出的HIV-HIV-1 Envs。如果成功的话,该项目将描绘出复杂而冗长的B细胞免疫学过程,揭示HIV-1 Env抗原启动有效抗体反应所需的备受期待的初始步骤。该项目还将生成一组BNAB对应的N/F BCR,这对于免疫原筛查是无价的,并且还可以鉴定有可能启用这些N/F BCR的HIV-1 ENV。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xueling Wu其他文献
Xueling Wu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xueling Wu', 18)}}的其他基金
Characterization of HIV-1 IgA bNAbs and ADCP function
HIV-1 IgA bNAb 的表征和 ADCP 功能
- 批准号:
10686968 - 财政年份:2022
- 资助金额:
$ 65.91万 - 项目类别:
Characterization of HIV-1 IgA bNAbs and ADCP function
HIV-1 IgA bNAb 的表征和 ADCP 功能
- 批准号:
10548376 - 财政年份:2022
- 资助金额:
$ 65.91万 - 项目类别:
Characterization of HIV-1 IgA bNAbs and ADCP function
HIV-1 IgA bNAb 的表征和 ADCP 功能
- 批准号:
10529017 - 财政年份:2021
- 资助金额:
$ 65.91万 - 项目类别:
Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies
用于有效分离广泛中和抗体的新型 HIV-1 Env 三聚体探针
- 批准号:
9335273 - 财政年份:2016
- 资助金额:
$ 65.91万 - 项目类别:
Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies
用于有效分离广泛中和抗体的新型 HIV-1 Env 三聚体探针
- 批准号:
10080301 - 财政年份:2016
- 资助金额:
$ 65.91万 - 项目类别:
Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing Antibodies
深度测序鉴定 HIV-1 中和抗体的 B 细胞前体
- 批准号:
8789709 - 财政年份:2014
- 资助金额:
$ 65.91万 - 项目类别:
Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing Antibodies
深度测序鉴定 HIV-1 中和抗体的 B 细胞前体
- 批准号:
8865551 - 财政年份:2014
- 资助金额:
$ 65.91万 - 项目类别:
Characterization and Generalization of a Novel Immunogenic Target on HIV-1 gp120
HIV-1 gp120 新型免疫原性靶点的表征和推广
- 批准号:
8812773 - 财政年份:2014
- 资助金额:
$ 65.91万 - 项目类别:
Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing Antibodies
深度测序鉴定 HIV-1 中和抗体的 B 细胞前体
- 批准号:
9285702 - 财政年份:2014
- 资助金额:
$ 65.91万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
- 批准号:
10659658 - 财政年份:2023
- 资助金额:
$ 65.91万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 65.91万 - 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 65.91万 - 项目类别:
Supplement for Role of Environmental Weathering and Gastrointestinal Digestion on the Bioavailability and Toxicity of Microplastic and Cadmium Mixtures
补充环境风化和胃肠消化对微塑料和镉混合物的生物利用度和毒性的作用
- 批准号:
10854398 - 财政年份:2023
- 资助金额:
$ 65.91万 - 项目类别:
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 65.91万 - 项目类别: